Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lu Daopei Hospital
Beijing, China
- Ownership
- Private
- Employees
- ~700
- Development stage
- Other
01
Overview
Lu Daopei Hospital is a leading center for hematopoietic stem cell transplantation and CAR-T therapy in China, with reported over 90% remission in B-cell ALL and high remission rates in other hematologic malignancies. It operates the largest bone marrow transplant group for leukemia treatment in the world and treats tens of thousands of patients annually.[1][2][3][6]
- Therapeutic areas
- OncologyHematology
- Modalities
- Cell therapyCAR-T cell therapyStem cell therapy
- Industry
- Academic Hospital/University/Research
02
Partnerships
HK HIS
Beyond the preview
Go deeper on Lu Daopei Hospital.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lu Daopei Hospital.